FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010207831> ?p ?o ?g. }

• W2010207831 endingPage "2096" @default.
• W2010207831 startingPage "2087" @default.
• W2010207831 abstract "In previous phase 1-2 clinical trials involving older adults, a subunit vaccine containing varicella-zoster virus glycoprotein E and the AS01B adjuvant system (called HZ/su) had a clinically acceptable safety profile and elicited a robust immune response.We conducted a randomized, placebo-controlled, phase 3 study in 18 countries to evaluate the efficacy and safety of HZ/su in older adults (≥50 years of age), stratified according to age group (50 to 59, 60 to 69, and ≥70 years). Participants received two intramuscular doses of the vaccine or placebo 2 months apart. The primary objective was to assess the efficacy of the vaccine, as compared with placebo, in reducing the risk of herpes zoster in older adults.A total of 15,411 participants who could be evaluated received either the vaccine (7698 participants) or placebo (7713 participants). During a mean follow-up of 3.2 years, herpes zoster was confirmed in 6 participants in the vaccine group and in 210 participants in the placebo group (incidence rate, 0.3 vs. 9.1 per 1000 person-years) in the modified vaccinated cohort. Overall vaccine efficacy against herpes zoster was 97.2% (95% confidence interval [CI], 93.7 to 99.0; P<0.001). Vaccine efficacy was between 96.6% and 97.9% for all age groups. Solicited reports of injection-site and systemic reactions within 7 days after vaccination were more frequent in the vaccine group. There were solicited or unsolicited reports of grade 3 symptoms in 17.0% of vaccine recipients and 3.2% of placebo recipients. The proportions of participants who had serious adverse events or potential immune-mediated diseases or who died were similar in the two groups.The HZ/su vaccine significantly reduced the risk of herpes zoster in adults who were 50 years of age or older. Vaccine efficacy in adults who were 70 years of age or older was similar to that in the other two age groups. (Funded by GlaxoSmithKline Biologicals; ZOE-50 ClinicalTrials.gov number, NCT01165177.)." @default.
• W2010207831 created "2016-06-24" @default.
• W2010207831 creator A5007727405 @default.
• W2010207831 creator A5011527812 @default.
• W2010207831 creator A5015707265 @default.
• W2010207831 creator A5016458115 @default.
• W2010207831 creator A5018086400 @default.
• W2010207831 creator A5031585842 @default.
• W2010207831 creator A5033658596 @default.
• W2010207831 creator A5044901968 @default.
• W2010207831 creator A5045598104 @default.
• W2010207831 creator A5047153448 @default.
• W2010207831 creator A5051264386 @default.
• W2010207831 creator A5068224827 @default.
• W2010207831 creator A5078675697 @default.
• W2010207831 creator A5078783858 @default.
• W2010207831 creator A5088320309 @default.
• W2010207831 date "2015-05-28" @default.
• W2010207831 modified "2023-10-18" @default.
• W2010207831 title "Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults" @default.
• W2010207831 cites W1825495625 @default.
• W2010207831 cites W1942950379 @default.
• W2010207831 cites W1972250137 @default.
• W2010207831 cites W1983893350 @default.
• W2010207831 cites W1991601117 @default.
• W2010207831 cites W1992354372 @default.
• W2010207831 cites W1996563874 @default.
• W2010207831 cites W1996764255 @default.
• W2010207831 cites W1996985859 @default.
• W2010207831 cites W2004409227 @default.
• W2010207831 cites W2004718706 @default.
• W2010207831 cites W2007492747 @default.
• W2010207831 cites W2034219960 @default.
• W2010207831 cites W2049032649 @default.
• W2010207831 cites W2049624058 @default.
• W2010207831 cites W2055017188 @default.
• W2010207831 cites W2055629718 @default.
• W2010207831 cites W2057919554 @default.
• W2010207831 cites W2078394827 @default.
• W2010207831 cites W2085802287 @default.
• W2010207831 cites W2089359789 @default.
• W2010207831 cites W2091217595 @default.
• W2010207831 cites W2112258538 @default.
• W2010207831 cites W2123574813 @default.
• W2010207831 cites W2131041950 @default.
• W2010207831 cites W2131427505 @default.
• W2010207831 cites W2133748820 @default.
• W2010207831 cites W2141655221 @default.
• W2010207831 cites W2145061830 @default.
• W2010207831 cites W2149820050 @default.
• W2010207831 cites W2149883005 @default.
• W2010207831 cites W2168766239 @default.
• W2010207831 doi "https://doi.org/10.1056/nejmoa1501184" @default.
• W2010207831 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25916341" @default.
• W2010207831 hasPublicationYear "2015" @default.
• W2010207831 type Work @default.
• W2010207831 sameAs 2010207831 @default.
• W2010207831 citedByCount "937" @default.
• W2010207831 countsByYear W20102078312015 @default.
• W2010207831 countsByYear W20102078312016 @default.
• W2010207831 countsByYear W20102078312017 @default.
• W2010207831 countsByYear W20102078312018 @default.
• W2010207831 countsByYear W20102078312019 @default.
• W2010207831 countsByYear W20102078312020 @default.
• W2010207831 countsByYear W20102078312021 @default.
• W2010207831 countsByYear W20102078312022 @default.
• W2010207831 countsByYear W20102078312023 @default.
• W2010207831 crossrefType "journal-article" @default.
• W2010207831 hasAuthorship W2010207831A5007727405 @default.
• W2010207831 hasAuthorship W2010207831A5011527812 @default.
• W2010207831 hasAuthorship W2010207831A5015707265 @default.
• W2010207831 hasAuthorship W2010207831A5016458115 @default.
• W2010207831 hasAuthorship W2010207831A5018086400 @default.
• W2010207831 hasAuthorship W2010207831A5031585842 @default.
• W2010207831 hasAuthorship W2010207831A5033658596 @default.
• W2010207831 hasAuthorship W2010207831A5044901968 @default.
• W2010207831 hasAuthorship W2010207831A5045598104 @default.
• W2010207831 hasAuthorship W2010207831A5047153448 @default.
• W2010207831 hasAuthorship W2010207831A5051264386 @default.
• W2010207831 hasAuthorship W2010207831A5068224827 @default.
• W2010207831 hasAuthorship W2010207831A5078675697 @default.
• W2010207831 hasAuthorship W2010207831A5078783858 @default.
• W2010207831 hasAuthorship W2010207831A5088320309 @default.
• W2010207831 hasBestOaLocation W20102078311 @default.
• W2010207831 hasConcept C120665830 @default.
• W2010207831 hasConcept C121332964 @default.
• W2010207831 hasConcept C126322002 @default.
• W2010207831 hasConcept C142724271 @default.
• W2010207831 hasConcept C168563851 @default.
• W2010207831 hasConcept C187212893 @default.
• W2010207831 hasConcept C203014093 @default.
• W2010207831 hasConcept C204787440 @default.
• W2010207831 hasConcept C22070199 @default.
• W2010207831 hasConcept C2522874641 @default.
• W2010207831 hasConcept C27081682 @default.
• W2010207831 hasConcept C2776159415 @default.
• W2010207831 hasConcept C2777863537 @default.
• W2010207831 hasConcept C2780441014 @default.

• next